EducAR:实施一个多元组件战略,以改善类风湿性关节炎治疗的坚持
María Ahijón Lana1, Francisca Sivera Mascaró2,3, Antonio Fernández-Nebro4
1Hospital Universitario de la Princesa, Madrid, Spain maria.ahijon@salud.madrid.org.
RMD open
|February 28, 2025
概括
基于EULAR需要考虑的要点 (PtC) 的新策略的实施并没有改善类风湿性关节炎 (RA) 治疗的坚持. 由于时间限制和现有的护理标准 (SOC) 等障碍,实施率较低,这可能解释了不确的结果.
科学领域:
- 类风湿病学 类风湿病学
- 数字健康干预措施 数字健康干预措施
- 患者坚持的研究研究.
背景情况:
- 欧洲风湿病学协会联盟 (EULAR) 制定了要考虑的要点 (PtC),以解决不遵守问题.
- 实施这些指导方针对于改善类风湿性关节炎 (RA) 等慢性疾病患者的治疗结果至关重要.
研究的目的:
- 设计,实施和评估旨在提高RA患者治疗坚持性的战略,以EULAR PtC为基础.
- 与标准护理 (SOC) 相比,评估一种新型干预措施在改善药物服药时的有效性.
主要方法:
- 一个多学科小组共同创建了一个基于EULAR PtC的数字干预.
- 一个集群随机试验将干预组与SOC组进行了比较.
- 在最近被诊断 (<2年) 的RA患者中,在6个月内测量了启动和实施的坚持.
主要成果:
- 该干预包括一个双面网站,面向患者 (教育,自我管理,同行支持) 和医疗保健专业人员 (沟通技巧,共享决策工具).
- 两组都显示了增加的坚持,但对照组 (SOC) 与干预组 (42%至47%) 相比,经历了更大的改善 (48%至67%).
- 观察到干预的实施率很低,这归因于时间限制,关注度不足以及当前SOC的充分性等障碍.
结论:
- 设计的干预措施,尽管是基于证据的,但在RA治疗坚持改善方面产生了不确定的结果.
- 干预的有限实施是一个重要的因素,阻碍了其潜在的影响.
- 所需变革的复杂性,包括医疗保健机构内的文化转变,可能需要更强大的实施策略.
相关概念视频
Drug Therapy
34
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
34
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
Drug Administration and Therapy Phases: Overview
402
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
402


